| [1] |
Brierley J, Sherman E. The role of external beam radiation and targeted therapy in thyroid cancer[J]. Semin Radiat Oncol, 2012, 22(3): 254-262.
|
| [2] |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133.
|
| [3] |
Kiess AP, Agrawal N, Brierley JD, et al. External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society[J]. Head Neck, 2015, 38(4): 493-498.
|
| [4] |
Radowsky JS, Howard RS, Burch HB, et al. Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome[J]. Thyroid, 2014, 24(2): 241-244.
|
| [5] |
Rivera M, Ricarte–Filho J, Tuttle RM, et al. Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension[J]. Thyroid, 2010, 20(10): 1085–1093.
|
| [6] |
Shindo ML, Caruana SM, Kandil E, et al. Management of invasive well-differentiated thyroid cancer: an American Head and Neck Society consensus statement. AHNS consensus statement[J]. Head Neck, 2014, 36(10): 1379–1390.
|
| [7] |
Sia MA, Tsang RW, Panzarella T, et al. Differentiated thyroid cancer with extrathyroidal extension: prognosis and the role of external beam radiotherapy[J]. J Thyroid Res, 2010: 183461.
|
| [8] |
Giuliani M, Brierley J. Indications for the use of external beam radiation in thyroid cancer[J]. Curr Opin Oncol, 2014, 26(1): 45-50.
|
| [9] |
Rosenbluth BD, Serrano V, Happersett L, et al. Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer[J]. Int J Radiat Oncol Biol Phys, 2005, 63(5): 1419–1426.
|
| [10] |
Lee NY, Lu JJ. Target volume delineation and field setup[M]. Berlin: Springer–Verlag, 2013: 59–64.
|
| [11] |
Romesser PB, Sherman EJ, Shaha AR, et al. External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer[J]. J Surg Oncol, 2014, 110(4): 375–382.
|
| [12] |
Mehrotra PK, Mishra A. Response to "Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering Cancer Center experience" (Int J Radiat Oncol Biol Phys 2009, 73: 795-801)[J]. Int J Radiat Oncol Biol Phys, 2010, 76(1): 314.
|
| [13] |
Chow SM, Yau S, Kwan CK, et al. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition[J]. Endocr Relat Cancer, 2006, 13(4): 1159–1172.
|
| [14] |
Schwartz DL, Lobo MJ, Ang KK, et al. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment[J]. Int J Radiat Oncol Biol Phys, 2009, 74(4): 1083-1091.
|
| [15] |
O’Neill CJ, Oucharek J, Learoyd D, et al. Standard and emerging therapies for metastatic differentiated thyroid cancer[J]. Oncologist, 2010, 15(2): 146-156.
|
| [16] |
Brose MS, Nutting CM, Jarzab B, et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial[J]. Lancet, 2014, 384(9940): 319–328.
|
| [17] |
Fussey JM, Crunkhorn R, Tedla M, et al. External beam radiotherapy in differentiated thyroid carcinoma: a systematic review[J]. Head Neck, 2016, 38(Suppl 1): E2297-2305
|
| [18] |
Brierley JD, Schwartz DL, Tsang RW. External beam radiotherapy for thyroid malignancy. In: Randolph GW, editor. Surgery of the thyroid and parathyroid glands[M]. Philadelphia: Elsevier, 2013.
|
| [19] |
Keum KC, Suh YG, Koom WS, et al. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea[J]. Int J Radiat Oncol Biol Phys, 2006, 65(2): 474–480.
|
| [20] |
Azrif M, Slevin NJ, Sykes AJ, et al. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation[J]. Radiother Oncol, 2008, 89(1): 105–113.
|
| [21] |
Kim YS, Choi JH, Kim KS, et al. The role of adjuvant external beam radiation therapy for papillary thyroid carcinoma invading the trachea[J]. Radiat Oncol J, 2017, 35(2): 112-120.
|
| [22] |
Tam S, Amit M, Boonsripitayanon M, et al. Adjuvant external beam radiotherapy in locally advanced differentiated thyroid cancer[J]. JAMA Otolaryngol Head Neck Surg, 2017, 143(12): 1244-1251.
|
| [23] |
Terezakis SA, Lee KS, Ghossein RA, et al. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering Cancer Center experience[J]. Int J Radiat Oncol Biol Phys, 2009, 73(3): 795-801.
|
| [24] |
Haymart MR, Banerjee M, Yin H, et al. Marginal treatment benefit in anaplastic thyroid cancer[J]. Cancer, 2013, 119(17): 3133-3139.
|
| [25] |
Troch M, Koperak O, Scheuba C, et al. High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel[J]. J Clin Endocrinol Metab, 2010, 95(9): E54-E57.
|
| [26] |
Foote RL, Molina JR, Kasperbauer JL, et al. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy[J]. Thyroid, 2011, 21(1): 25-30.
|
| [27] |
Hu CK, Kuo LT, Hong WC, et al. Sarcoma of the cervical spine after radiation treatment for thyroid cancer[J]. Spine, 2010, 35(9): E363-E367.
|
| [28] |
Yang Z, Flores J, Katz S, et al. Comparison of survival outcomes following postsurgical radioactive iodine versus external beam radiation in stage Ⅳdifferentiated thyroid carcinoma[J]. Thyroid, 2017, 27(7): 944-952.
|
| [29] |
So K, Smith RE, Davis SR. Radiotherapy in well-differentiated thyroid cancer: is it underutilized?[J]. ANZ J Surg, 2016, 86(9): 696-700.
|